Wide Ranks

IBO

Impact BioMedical, Inc.

2.75

Top Statistics
Market Cap 31 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 2.79 Trailing PE 27.50 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -14.20 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 2 M Total Cash Per Share 0.2320 Total Debt 8 M
Total Debt To Equity 23.31 Current Ratio 2.79 Book Value Per Share 2.72
All Measures
Short Ratio 8.00 % Message Board Id finmb_644355879 Shares Short Prior Month 71284
Return On Equity 0.0345 City Houston Uuid df83e044-d3e1-3f4b-8b15-4507c6ac3a79
Previous Close 2.73 First Trade Date Epoch Utc 1 B Book Value 2.72
Total Debt 8 M Volume 6195 Price To Book 1.01
Fifty Two Week Low 1.22 Total Cash Per Share 0.2320 Shares Short Previous Month Date 1 B
Max Age 86400 Sand P52 Week Change 0.3133 Net Income To Common 1 M
Ask 2.83 Implied Shares Outstanding 11 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 58610 Average Volume10days 58610
Total Cash 2 M Next Fiscal Year End 1 B Held Percent Insiders 0.5514
Trailing PE 27.50 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 2.73 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.17 Open 2.75 Free Cashflow -1329125
State TX Dividend Yield 0.00 % Return On Assets -0.0499
Time Zone Short Name EST Trailing Eps 0.1000 Day Low 2.60
Address1 1400 Broadfield Blvd. Shares Outstanding 11 M Price Hint 4
Target High Price 0.0000 Website https://www.impactbiomedinc.com 52 Week Change 0.0261
Average Volume 94105 Recommendation Key none Forward Eps 0.0000
Compensation As Of Epoch Date 1 B Quick Ratio 234.40 % Is_sp_500 False
Regular Market Day High 2.75 Profit Margins 0.00 % Debt To Equity 23.31
Fifty Two Week High 3.25 Day High 2.75 Shares Short 5081
Regular Market Open 2.75 Industry Key biotechnology Bid 2.50
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0022
Operating Cashflow -3096000 Currency USD Time Zone Full Name America/New_York
Market Cap 31 M Is_nasdaq_100 False Zip 77084
Quote Type EQUITY Industry Biotechnology Long Name Impact BioMedical Inc.
Regular Market Day Low 2.60 Held Percent Institutions 0.0139 Current Price 2.75
Address2 Suite 130 Enterprise To Ebitda -14.20 Financial Currency USD
Current Ratio 2.79 Industry Disp Biotechnology Country United States
Float Shares 5 M Two Hundred Day Average 2.18 Enterprise Value 40 M
Forward PE 0.0000 Regular Market Volume 6195 Ebitda -2820000
Exchange ASE
Go to Yahoo Finance Go to Seeking Alpha 
Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States.

The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone.

It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances.

In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications.

Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas.